Ardent Health, Inc.
For the period ended Mar 31, 2025. Filed May 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 7, 2025
ARDT$17.30+8.8%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Table of Contents
| Page | ||
|---|---|---|
| PART I. · FINANCIAL INFORMATION | ||
| Item 1. | Financial Statements | 1 |
| Condensed Consolidated Income Statements for the three months ended March 31, 2025 and 2024 (Unaudited) | 1 | |
| Condensed Consolidated Comprehensive Income Statements for the three months ended March 31, 2025 and 2024 (Unaudited) | 2 | |
| Condensed Consolidated Balance Sheets as of March 31, 2025 and December 31, 2024 (Unaudited) | 3 | |
| Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2025 and 2024 (Unaudited) | 4 | |
| Condensed Consolidated Statements of Changes in Equity for the three months ended March 31, 2025 and 2024 (Unaudited) | 5 | |
| Notes to Condensed Consolidated Financial Statements (Unaudited) | 6 | |
| Item 2. | Management's Discussion and Analysis of Financial Condition and Results of Operations | 20 |
| Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 36 |
| Item 4. | Controls and Procedures | 36 |
| PART II. | OTHER INFORMATION | |
| Item 1. | Legal Proceedings | 37 |
| Item 1A. | Risk Factors | 37 |
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 37 |
| Item 3. | Defaults Upon Senior Securities | 37 |
| Item 4. | Mine Safety Disclosures | 37 |
| Item 5. | Other Information | 37 |
| Item 6. | Exhibits | 38 |
| Signatures | 39 | |
CONDENSED CONSOLIDATED INCOME STATEMENTS
(Dollars in thousands, except per share amounts)
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Total revenue | $1,497,234 | $1,439,046 |
| Expenses: | ||
| Salaries and benefits | 657,652 | 621,509 |
| Professional fees | 280,857 | 264,694 |
| Supplies | 258,855 | 257,781 |
| Rents and leases | 27,761 | 24,855 |
| Rents and leases, related party | 38,050 | 37,199 |
| Other operating expenses | 130,767 | 121,832 |
| Interest expense | 14,176 | 19,261 |
| Depreciation and amortization | 36,201 | 35,351 |
| Other non-operating gains | (21,283) | — |
| Total operating expenses | 1,423,036 | 1,382,482 |
| Income before income taxes | 74,198 | 56,564 |
| Income tax expense | 15,233 | 10,713 |
| Net income | 58,965 | 45,851 |
| Net income attributable to noncontrolling interests | 17,582 | 18,804 |
| Net income attributable to Ardent Health Partners, Inc. | $41,383 | $27,047 |
| Net income per share: | ||
| Basic | $0.30 | $0.21 |
| Diluted | $0.29 | $0.21 |
| Weighted-average common shares outstanding: | ||
| Basic | 140,062,284 | 126,115,301 |
| Diluted | 140,704,075 | 126,115,301 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.